نتایج جستجو برای: cyclophosphamide drug

تعداد نتایج: 611229  

Journal: :Cancer research 1993
T K Chang G F Weber C L Crespi D J Waxman

The present study identifies the specific human cytochrome P-450 (CYP) enzymes involved in hydroxylation leading to activation of the anticancer drug cyclophosphamide and its isomeric analogue, ifosphamide. Substantial interindividual variation (4-9-fold) was observed in the hydroxylation of these oxazaphosphorines by a panel of 12 human liver microsomes, and a significant correlation was obtai...

2006
M. C. Alley G. Powis P. L. Appel K. L. Kooistra M. M. Lieber

While colony formation assays provide sensitive indices of tumor cell proliferation and growth inhibition imposed by many Chemotherapeutic agents, drugs which require metabolic acti vation lack activity in such assays. In the present study, we have utilized freshly isolated rat hepatocytes for the activation of drugs which are metabolized by hepatic microsomal as well as extramicrosomal enzymes...

Journal: :Cancer research 1984
M C Alley G Powis P L Appel K L Kooistra M M Lieber

While colony formation assays provide sensitive indices of tumor cell proliferation and growth inhibition imposed by many chemotherapeutic agents, drugs which require metabolic activation lack activity in such assays. In the present study, we have utilized freshly isolated rat hepatocytes for the activation of drugs which are metabolized by hepatic microsomal as well as extra-microsomal enzymes...

2007

J The present study identifies the specific human cytochrome P-450 (CYP) enzymes involved in hydroxylation leading to activation of the anticancer drug cyclophosphamide and its isomeric analogue, ifosphamide. Substantial interindividual variation (4-9-fold) was observed in the hydroxylation of these oxazaphosphorines by a panel of 12 human liver microsomes, and a significant correlation was obt...

Journal: :Cancer research 2006
Raquel Munoz Shan Man Yuval Shaked Christina R Lee John Wong Giulio Francia Robert S Kerbel

Metronomic antiangiogenic chemotherapy, the prolonged administration of relatively low drug doses, at close regular intervals with no significant breaks, has been mainly studied at the preclinical level using single chemotherapeutic drugs, frequently in combination with a targeted antiangiogenic drug, and almost always evaluated on primary localized tumors. We tested a "doublet" combination met...

2007

J The present study identifies the specific human cytochrome P-450 (CYP) enzymes involved in hydroxylation leading to activation of the anticancer drug cyclophosphamide and its isomeric analogue, ifosphamide. Substantial interindividual variation (4-9-fold) was observed in the hydroxylation of these oxazaphosphorines by a panel of 12 human liver microsomes, and a significant correlation was obt...

2016
Donald P Tashkin Michael D Roth Philip J Clements Daniel E Furst Dinesh Khanna Eric C Kleerup Jonathan Goldin Edgar Arriola Elizabeth R Volkmann Suzanne Kafaja Richard Silver Virginia Steen Charlie Strange Robert Wise Fredrick Wigley Maureen Mayes David J Riley Sabiha Hussain Shervin Assassi Vivien M Hsu Bela Patel Kristine Phillips Fernando Martinez Jeffrey Golden M Kari Connolly John Varga Jane Dematte Monique Hinchcliff Aryeh Fischer Jeffrey Swigris Richard Meehan Arthur Theodore Robert Simms Suncica Volkov Dean E Schraufnagel Mary Beth Scholand Tracy Frech Jerry A Molitor Kristin Highland Charles A Read Marvin J Fritzler Grace Hyun J Kim Chi-Hong Tseng Robert M Elashoff

BACKGROUND 12 months of oral cyclophosphamide has been shown to alter the progression of scleroderma-related interstitial lung disease when compared with placebo. However, toxicity was a concern and without continued treatment the efficacy disappeared by 24 months. We hypothesised that a 2 year course of mycophenolate mofetil would be safer, better tolerated, and produce longer lasting improvem...

2015
Ibrahim El-Serafi Parvaneh Afsharian Ali Moshfegh Moustapha Hassan Ylva Terelius Xinghui Qiu

INTRODUCTION Cyclophosphamide is commonly used as an important component in conditioning prior to hematopoietic stem cell transplantation, a curative treatment for several hematological diseases. Cyclophosphamide is a prodrug activated mainly by cytochrome P450 2B6 (CYP2B6) in the liver. A high degree of inter- and intra-individual variation in cyclophosphamide kinetics has been reported in sev...

2006
Lynn Clarke David J. Waxman

Cytochrome P-450-catalyzed activation of Cyclophosphamide to alkylating metabolites was studied in isolated rat liver microsomes and puri fied, reconstituted P-450 enzyme systems in order to identify the major enzymatic catalysts of drug activation in both uninduced and drug-induced liver tissue. P-450 form PB-4 (P-450 gene UBI) activated Cyclophospha mide with high efficiency [\ „¿ ,», (app...

Journal: :European review for medical and pharmacological sciences 2017
Q-S Zhou J Hu H Hu

OBJECTIVE To investigate the therapeutic effect of drug therapy with cyclophosphamide and leflunomide on the joint function damage of patients with systemic lupus erythematosus (SLE) and its regulatory effects on expression levels of programmed death receptor 1, Notch signaling pathway genes and interferon-inducible protein 10 in peripheral blood mononuclear cells. PATIENTS AND METHODS A tota...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید